Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
TOXICOLOGY PEARLS
Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN Toxicology Nurse Practitioner
1 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
DISCLOSURES
Nancy Denke, DNP, FNP-BC, ACNP-BC, FAEN, CEN, CCRN has no financial relationships with commercial interests to disclose
Any unlabeled/unapproved uses of drugs or products referenced will be disclosed
2 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
OBJECTIVES
• Describe tools/pearls that can be used to identify commonly seen toxicological conditions
• Assimilate toxicological facts into a framework of knowledge
• Describe the signs and symptoms of common exposures
3 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
DRUG INDUCED QTC PROLONGATION
• Aspirin • Guaifenesin • Loperamide • Pseudoephedrine • Senna
4 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
A NEW CUP OF COFFEE
5 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CASE
• 56 y.o. male asked to consult for evaluation and treatment transaminitis • Notes that while in Hawaii (arrived 2/20/21) he noted abdominal pain, nausea, clay-colored stools, dark urine, decreased appetite and a headache • Prior to this trip he had been sick with a respiratory problem and was on a regimen of steroids (prednisone) and amoxicillin. • In December he stopped taking his BP meds and began taking an herbal mushroom powder that his son recommended along with numerous other herbal supplements (listed below). • Comes to ED on 2/28/21 with weakness and abdominal pain- along with "yellowing of his eyes". • Current symptoms include: down trending of transaminitis, slight decreased appetite
6 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
OTHER INFORMATION
• Supplements • Mushroom powder (Mudwater) • Green Vibrance • Puerh Tea with B pollen (with AZ Rango honey) • Ginseng • Ginseng with royal jelly • Wheat germ • Wheat grass • Thyme extract- a tincture • Fish oil • Gingko
7 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
REISHI MUSHROOM (GANODERMA LUCIDUM)
OTHER EFFECTS
8 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
SHROOMS MAGIC MUSHROOMS
• Magic mushrooms cause physical and psychological effects • Street name for mushrooms containing psilocybin • Famous for causing hallucinations • Causes a wide range of effects because it’s chemically similar to serotonin • Long-term side effects include flashbacks and memory problems
9 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CAN MAGIC MUSHROOMS MEASURE UP TO SSRIS FOR DEPRESSION TREATMENT?
10 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
11 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
WHAT 3 SPICES ARE COMMONLY ABUSED
12 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
I WILL HUFF AND I WILL PUFF
13 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
SOME STATISTICS
• Over 2.6 million children, aged 12 to 17 uses an inhalant, each year to get high • 1 in 4 students in America has intentionally abused the common household product, Air Duster, to get high by the time they reach 8th grade • 59% children are aware of friends huffing at age 12 • Inhalants are 4th most-abused substance after alcohol, tobacco and marijuana
14 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
https://www.drugabuse.gov/drug-topics/inhalants/inhalants-trends-statistics
15 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
AIR DUSTERS • Inhalants everyday household products • Who does it? • Usually, pre-teens and teenagers • Nearly one in five 8th graders has tried • When? • Before school. During school. After school. Nights. Weekends. • Why? • In the words of one teen, "Because they can. Because they're bored! Because they're upset." In short, for any reason or no reason!
High is euphoric but short term!
16 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CASE STUDY
• 20 yo male brought to the ED by PD for erratic driving • Altered mental status & ingestion of alprazolam & oxy PMH- untreated HTN • 3 cans of Dust-Off (only 1 empty) In ED • High flow oxygen, ABG • ECG • Check Mg and lytes
17 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
18 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
•Dizziness •Lightheadedness •Nausea •Headache SHORT TERM •Confusion/Hallucinations EFFECTS •Slurred speech •Loss of motor control and coordination •Seizures
19 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
• Weight loss • Depression/Mood changes LONG • Muscle spasms TERM • Arrhythmias EFFECTS • Damage to lungs and kidneys
20 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
RECOGNIZING ABUSE OF CANNED AIR
• Empty cans of canned air in trashcans or in one’s room or car • Presence of Dust-Off in easy-to-reach locations (e.g., bedside table, handbag, etc.) • Hoarseness and complaints of numb tongue or throat • Bloodshot eyes • Out-of-character behaviors and an overall change in social circle
21 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
QUESTION BREAK
22 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
WHAT WAS THE KEY INGREDIENT IN MRS. WINSLOW’S SOOTHING SYRUP
• Morphine sulfate 65 mg/oz & alcohol
• Used for babies who were crying, teething, or had dysentery
• Sold more than 1.5 million bottles of the remedy annually & sold until the 1930s
23 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
BUT IT’S ONLY TYLENOL
24 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CASE
• A 73yo M presents with confusion and weakness • Appears jaundiced and unable to provide history • Hx previous admissions for alcohol use • CBC, electrolytes, creatinine, liver enzymes, coagulation studies, and EtOH level • Severe elevations in AST, ALT, ALP and bilirubin • EtOH level is 70mg/dL • What additional bloodwork in this patient could reveal a treatable cause of acute liver failure?
25 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
Acetaminophen (APAP) most widely used OTC pain reliever & antipyretic worldwide
Peak serum transaminase usually occur 48-96h after acute ingestion
Acute OD, most adults must ingest ≈ >12 g APAP before risk of serious hepatotoxicity is of concern OVERVIEW Nomogram of serum APAP concentration vs hours post-ingestion
Patients can present in liver failure days after ingestion with undetectable serum APAP levels and renal failure NAC's main action is to maintain intracellular glutathione stores so to detoxify APAP metabolite, NAPQI
26 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
Rumack-Matthew Nomogram
https://en.wikipedia.org/wiki/File:Rumack _Matthew_nomogram_with_treatment_ (study)_line.pdf
27 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
STAGES OF ACETAMINOPHEN TOXICITY
Stead, T. S., Jeong, J. Y., Ganti, L., & Rubero, J. (2020). Massive Acetaminophen Overdose. Cureus, 12(7), e9262. https://doi.org/10.7759/cureus.9262
28 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
APAP TREATMENT
• If time or amount of ingestion is unknown or if ingestion spans more than 24 hours: • Screen with labs (APAP level, hepatic and renal function, coagulation) • Assess patient risk factors • Clinical assessment • If ASTs are elevated - NAC 2 bag • If APAP is detectable - Treat with 2 bag NAC • If APAP not detectable and ASTs are normal - No NAC indicated • If lab testing shows progressive hepatic failure - Repeat infusion of Bag # 2 (16- hour bag)
29 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
WHAT STREET DRUG CAN CAUSE THIS
COCAINE
Bhagavathula A. et.al. (2020). Cocaine-induced vasculitis. The American Journal of Gastroenterology, 115, S 1609-1610
30 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
PHENIBUT AN EMERGING “DIETARY SUPPLEMENT”
31 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CASE
• 30 y.o. male consult for evaluation and treatment Phenibut ingestion • He admits to using phenibut sometime yesterday and became very anxious and altered as the evening progressed this worsened until his friend became so concerned that he brought him to the ED to be seen • Patient notes that he has abused "the stuff" previously and then began taking it again • Had psychosis from using & this is why he stopped. Upset because "I screwed up and lost the best job I ever had as a coach" • Unable to tell me how much he uses on a daily basis • Current symptoms include: alert, confused, but redirectable • Circumstances behind ingestion include: to help with anxiety • BP 137/91, Pulse 79 Temp 98 °F (36.7 °C) (Oral) , Resp 18
32 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
WHAT IS PHENIBUT?
• Supplement started in Russia in the 1960s, prescribed as an anti- anxiety med to treat depression, insomnia, PTSD, and stuttering
• Potent psychoactive substance with GABAB agonist properties • Can be purchased easily online & marketed as a nutritional supplement but in practice used for psychotropic effects with potential for abuse • Known as a mood enhancer, sleep aid, exercise recovery booster, and even a “smart drug” currently sold as a nootropic
Jouney E.A. (2019). Phenibut (β-Phenyl-γ-Aminobutyric Acid): An easily obtainable "Dietary Supplement" with propensities for physical dependence and addiction. Current Psychiatry Reports. 21(4),23 doi:10.1007/s11920-019-1009-0. PMID: 30852710.
33 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
INTERNET INFLUENCE IN OPENING ACCESS TO A WIDE RANGE OF RECREATIONAL AGENTS OF ABUSE
• Exposure calls to a Minnesota poison center from January 2000 through December 2018 regarding Phenibut • Saw an increase over 5year period (2014-2019) • CNS depression and respiratory failure requiring intubation
34 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
Hardman M.I., Sprung J. & Weingarten T.N. (2019).
35 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
TREATMENT PLAN
• Phenibut is an analog of the neurotransmitter GABA and is a GABA- B agonist, can causing variable clinical toxicity, ranging from coma/sedation to agitation and seizures • Patient presenting with psychosis and confusion, which can be consistent • Recommend symptomatic management • In severe withdrawal, such as with seizures, then can consider GABA-A agonists such as benzodiazepines, phenobarbital, or GABA-B agonists such as baclofen.
36 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
SIDE EFFECTS
• Phenibut withdrawal may mimic benzodiazepine withdrawal with symptoms including anxiety, insomnia, and tension
• Baclofen use for phenibut withdrawal given its similar molecular structure and mechanism of action
Hardman M.I., Sprung J. & Weingarten T.N. (2019).
37 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
WHIPPETS “NO LAUGHING MATTER”
38 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
HOW THEY ARE USED
• Empty balloons and balloons smelling of strange chemicals are signs of inhalant abuse • Increasing at festivals with the gas filled balloons
39 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CASE STUDY
40 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
30 Y.O MALE
• Bilateral weakness to lower (bilateral) extremities for 1 week • Was using 50-100 whippets/day at least 4x/week for 1 year until 3/20 • Went to detox and was discharged on 3/25. He notes that about 1 week ago he began to have some difficulties lifting his feet (worse on than R). He also noted some pain to that area. • Placed on a rivaroxaban 20 mg starter pack and ran out about 4 days ago and just got his Rx refilled today. He was started on this medication due to bilateral DVT of lower extremities which he notes is related to a genetic condition. • Current symptoms include: alert, cooperative. Able to ambulate with some balance issues with weakness noted to RLE.
41 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
EXAM
• Reflex Scores: • Tricep reflexes are 0 on the right side and 0 on the left side. • Bicep reflexes are 0 on the right side and 0 on the left side. • Patellar reflexes are 0 on the right side and 0 on the left side. • Achilles reflexes are 0 on the right side and 0 on the left side • Strength 5/5 except as below • Right anterior tibial: 0/5 • Left anterior tibial: 0/5 • Right peroneal: 0/5 • Left peroneal: 0/5
42 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
Savag & Ma, 2014
43 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
EXAM
• Sensory Exam • Right leg pinprick: decreased from ankle • Left leg pinprick: decreased from ankle
• Gait, Coordination, and Reflexes Reflexes Right biceps: 0 Left biceps: 0 Right triceps: 0 Left triceps: 0 Right patellar: 0 Left patellar: 0 Right achilles: 0 Left achilles: 0
44 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
Homocysteine elevated well before B12 deficiency detected
Megaloblastic Macrocytic Anemia EFFECTS OF NITROUS Other Signs and Symptoms
• Paralysis of lower body • Paresthesia & spasm extremities • Incontinence • Weak immune system
45 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
MYELOPATHY OR SUBACUTE DEGENERATION OF THE SPINAL CORD
• NO oxidizes B12, which is important for DNA synthesis and maintenance of the myelin sheath around nerve cells • MRI • Abuse of nitrites can result in dorsal and lateral spinal column disorders due to effects on B12 metabolism
46 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
MRI
• MRI Cervical • Straightening and slight reversal of cervical lordosis. 2. Mild cervical spondylosis, primarily at C5-6 and C6-C7. No evidence for significant spinal canal or neural foraminal stenosis. 3. No evidence for cord pathology. No abnormal cord enhancement. Specifically, no evidence for demyelinating disease • MRI Thoracic spine • Unremarkable MRI of the thoracic spine. No evidence for cord abnormality. Specifically, no evidence for demyelinating disease • MRI Lumbar • No evidence for conus pathology. No abnormal enhancement of the conus or nerve roots of the cauda equina. 2. Spondylitic changes, primarily at L4-5 and L5-S1 with left foraminal annular fissure and disc protrusion at L4-5. There is resultant narrowing of the left L4 neural foramen and minimal abutment of exiting left L4 nerve root
47 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
HOW TO TREAT
• Personality changes subtle • IM B12 injection • Rehab- cognitive therapy
48 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
QUESTION BREAK
What common condition can this bug threat?
Warts and Molluscum Contagiosum
49 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
MEDICINAL CLEANSING RITUAL
A patient presents with her Shaman with nausea, vomiting, flushing and altered mental status after participating in a cleanse earlier that day You note this on her ankle
What is the exposure?
50 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
KAMBO • It is a deep cleansing treatment from the Amazon that is as old as legend • It is becoming more and more popular with the rest of the world these days due to its powerful effects. • Treatment entails creating small burns in the skin and the application of a small mound of reconstituted venom (gel) from an Amazonian giant tree frog called Phyllomedusa Bicolor • Kambo is absorbed through the lymphatic system
Li K et al. Prolonged toxicity from Kambo cleansing ritual. Clin Tox 2018; 56(11): 1165
51 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
ADVERSE EFFECTS • Symptoms attributed to the pharmacological activity of Kambo peptides • Effects on smooth muscles and blood vessels • Symptoms include BP, flushing, palpitation, n/v, bile secretion and angioedema • Symptom-complex NOT anaphylactic in nature, but directly related to Kambo pharmacological effects
52 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
A TALE OF INTRACTABLE VOMITING
• 43 yo male who works as a greenskeeper • Friend gave him a “cookie” that he began to eat at about 0600 and finished right before his 0800 meeting • Began vomiting and brought to ED at 1100 with intractable • VS. HR. 124 BP 110/68 • Vomited several times in the ED
53 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CANNABINOID HYPEREMESIS SYNDROME • With legalization of cannabis the presentation to ED’s for cyclic vomiting has nearly doubled • Pathophysiology of CHS is largely unknown
Criteria for this syndrome • Cyclic nausea and vomiting • Resolution with marijuana cessation • Hot showers/baths relieve symptoms • Abdominal pain • At least weekly use of marijuana (often daily)
Stinnett V.L. and. Kuhlmann K.L. (2018). Cannabinoid hyperemesis syndrome: An update for primary care providers. The Journal for Nurse Practitioners, 14(6),450-455
54 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
• Antiemetics • Ondansetron (Zofran®) • Prochlorperazine (Compazine) • Promethazine (Phenergan) • Haldol TREATMENT • Hot shower • Capsaicin cream 0.075% applied to the abdomen • Proton pump inhibitors
55 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
MIXING THC/CBD WITH SOME COMMON MEDICATIONS
• Warfarin –THC/CBD increases INR • Ketaconazole – can double the effects of THC/CBD, enhance effects • Rifampin- may decrease the effects of THC/CBD • Sulfamethoxazole- may increase level of THC, but no effect on CBD • Carbamazepine- may decrease levels of THC, no effects on CBD • Fluoxetine- no reaction with THC, but may have reaction with CBD • Valproate- with CBD can cause increased liver enzymes • Alcohol- increases THC levels
Because of all new laws and less restriction- always be aware of interaction with your patient’s medications https://www.drugs.com/drug-interactions/cannabis.html
56 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
HYDROGEN PEROXIDE
57 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
THIS “NATURAL CURE” CAN BE DEADLY
BROWN BOTTLE A SMALL AMOUNT OF A SIP ISN'T A GOOD OF 3 % DILUTED CONCENTRATED PEROXIDE IDEA, IT PROBABLY HYDROGEN (35%) ON CONTACT WITH PEROXIDE WOULDN'T MAKE YOU TISSUE RELEASES 100 ML OF SEVERELY ILL O2
58 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
SIDE EFFECTS
• In the 10-year retrospective study, 41 of 294 (13.9%) symptomatic peroxide ingestion cases demonstrated evidence of a possible embolic event • Time to onset of a possible embolic event varied greatly immediate-25 hours) • Ingestion of small amounts (mouthful or 2), of concentrated hydrogen peroxide led to critical illness caused by suspected embolism in 13.9% & severe long-term outcomes (death or continued disability) in 6.8% cases • Focal neurologic deficits suggestive of CVA, tachycardia, hypotension & suspected arterial embolic effects • Local injury to the gut vascular wall (extraluminal air)
59 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
TREATMENT
• Symptomatic care • Chest CT • Early hyperbaric oxygen therapy for gas embolism • Esophagogastroduodenoscopy (EGD) for caustic effects • Deep ulcerations, necrosis, GI bleed or pneumomediastinum found
60 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
WHAT WERE THE MOST COMMON FINDINGS IDENTIFIED IN CHILDREN EXPOSED TO METHAMPHETAMINE?
61 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
• Retrospective review done by Malashock HR, et al. (2021) of patients presenting to a pediatric tertiary care center HYPERTENSION identified 79 patients with AND suspected methamphetamine TACHYCARDIA toxicity • In addition to typical sympathomimetic findings, common symptoms identified in this population included abnormal motor activity and GI symptoms
62 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
ANTIDOTE CHALLENGE
Oleander leaves
Digoxin specific immune Fab fragments
63 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
OLEANDER INGESTION CASE
• 19 month old female who was with her mother at 1645 the child picked up a small pod from an oleander plant • The bottom part of the pod and possibly some of the seeds were a missing. It is unclear if the patient swallowed any of the pod or seeds. • The patient was admitted to the hospital for continued observation • Has been asymptomatic with normal vital signs and laboratory studies • 127/74 , Pulse 123, Temp 98.6 °F (37 °C) (Temporal). Resp 30 • Digoxin 0.2
64 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CALCIUM CHANNEL BLOCKER
65 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CALCIUM CHANNEL BLOCKER
• Severe toxicity is highly lethal, as a result of cardiovascular collapse • Good outcomes can be achieved with aggressive treatment • Verapamil and diltiazem most lethal calcium-channel blockers OD • Cardiac toxicity results from: • excessive negative inotropy: myocardial depression • negative chronotropy: sinus bradycardia • negative dromotropy: AV node blockade • Effects on vascular smooth muscle tone result in: • decreased afterload • systemic hypotension • coronary vasodilation
66 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CALCIUM CHANNEL BLOCKER
67 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
Hyperglycemia
Hypoinsulinemia METABOLIC EFFECTS Calcium channel blocker-induced insulin resistance Calcium channel blockers also impair the cardiac myocyte adaptive
response due to: • Uptake of glucose & free fatty acids by cardiac myocytes • Inhibition of Ca-dependent mitochondrial activity required for glucose catabolism
68 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
CLINICAL FEATURES
• Onset of symptoms typically within 1-2 hours of ingestion • Slow release preps onset delayed 12-16 hrs with peak effects after 24 hours • Early signs bradycardia, 1st degree block and hypotension • May progress to refractory shock and death • Complications may include MI, stroke and non-occlusive mesenteric ischemia • Hyperglycaemia • Seizures and coma are rare
69 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
LAB TEST THAT CAN BE PROGNOSTIC OF MORTALITY IN CALCIUM CHANNEL BLOCKER POISONING
• Serum lactate • In a recent retrospective review of 177 patients, initial blood lactate concentration accurately predicted CCB-poisoning related mortality • In this study, initial blood glucose concentrations was an early predictor for severity but not mortality
Chen C , Voicu S , Diallo A , et al. (2020). The severity and mortality prediction of calcium-channel blocker poisoning in the intensive care unit. Clinical Toxicology, 58(6):508
70 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
TREATMENT • Calcium can be a useful to increase HR and BP • 10% calcium gluconate 60mL IV (0.6-1.0 mL/kg in children) • 10% calcium chloride 20mL IV (0.2 mL/kg in children) • Glucagon 1-5 mg IV • Atropine: 0.6mg every 2 min up to 1.8 mg (often ineffective) • High dose insulin – euglycaemic therapy • 1 u/kg bolus then 0.5 u/kg/hr • Vasopressors & intotropic • Norepi or Epi • Intralipids • ECMO
71 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
Beta Blockers
ANTIDOTE CHALLENGE Glucagon, calcium gluconate or chloride, high-dose insulin euglycemic therapy, lipid emulsion
72 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
• A docuseries on Vice TV • The show follows a guy named Hamilton as he explores the history, chemistry, & social impact of psychoactive substances HAMILTON’S • It chronicles his travels PHARMACOPEIA and first-hand experiences, as well as interviews with scientists, shamans and culture figures • https://www.youtube.com/ watch?v=C3Yd7M3JNlw
73 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
74 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
REFERENCES
• Downs, J. W., Cumpston, K. L., Kershner, E. K., Troendle, M. M., Rose, S. R., & Wills, B. K. (2021). Clinical outcome of massive acetaminophen overdose treated with standard-dose N-acetylcysteine. Clinical Toxicology , 1–8. Advance online publication. https://doi.org/10.1080/15563650.2021.1887493 • Fisher, E. S., & Curry, S. C. (2019). Evaluation and treatment of acetaminophen toxicity. Advances in Pharmacology, 85, 263–272. https://doi.org/10.1016/bs.apha.2018.12.004 • Fratt K (2018). Everything you need to know about Reishi mushrooms. Retrieved from https://www.plantsnap.com/wp-content/uploads/2018/11/ganoderma-lucidum-bonsai-2641558_1920.jpg • Panchal AR, Bartos JA, Cabañas JG, et al; Adult Basic and Advanced Life Support Writing Group. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020 Oct 20;142(16_suppl_2):S366-S468. doi: 10.1161/CIR.0000000000000916. Epub 2020 Oct 21. PMID: 33081529. • Stead, T. S., Jeong, J. Y., Ganti, L., & Rubero, J. (2020). Massive acetaminophen overdose. Cureus, 12(7), e9262. https://doi.org/10.7759/cureus.9262 • Wanmuang, H., Leopairut, J., Kositchaiwat, C., Wananukul, W., & Bunyaratvej, S. (2007). Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 90(1), 179–181.
75 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
REFERENCES
• Ahuja T., Mgbako O., Katzman C., & Grossman A. (2018). Phenibut (β-Phenyl-γ-aminobutyric Acid) dependence and management of withdrawal: Emerging nootropics of abuse. Case Reports in Psychiatry, 9864285. https://doi.org/10.1155/2018/9864285 • Bhagavathula A., Linsteadt J., & Jaggi S. (2020). Cocaine-induced vasculitis. The American Journal of Gastroenterology, 115, S 1609-1610. doi:10.14309/01.ajg.0000714264.50841.7f • Carhart-Harris R., et. al (2012). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 38415), 1402-1411. DOI: 10.1056/NEJMoa2032994 • Coenen, N.C.B. Dijkstra, Boukje A.G,; Batalla, A., & Schellekens, A. (2019). Detoxification of a patient with comorbid dependence on Phenibut and Benzodiazepines by tapering with Baclofen. Journal of Clinical Psychopharmacology, 39(5), 511-514. doi: 10.1097/JCP.000000000000110 • Garakani A, Jaffe R.J, Savla D, Welch A.K, Protin C.A, Bryson E.O, & McDowell D.M. (2016. Neurolongic, psychiatric and other medical manifestaions of nitrous oxide abuse: A systematic review of care literature. American Journal of Addiction, 25(5), 358-369 • Hardman M.I., Sprung J. & Weingarten T.N. (2019). Acute phenibut withdrawal: A comprehensive literature review and illustrative case report. Bosnian Journal of Basic Medical Sciences, 19(2), 125-129. https://doi.org/10.17305/bjbms.2018.4008
76 Toxicology Pearls Nancy Denke ACNP-BC, FNP-BC, CEN, CCRN, FAEN B3
REFERENCES
• Hatten B.W, French L.K, Horowitz B.Z, & Hendrickson R.G. (2017). Outcomes after high- concentration peroxide ingestions. Annals of Emergency Medicine, 69(6), 726-736.e2. doi: 10.1016/j.annemergmed.2016.11.022. • Johnson-Arbor K, Smolinske S. (2021). Stoned on spices: A mini-review of three commonly abused household spices. Clinical Toxicology. 59(2), 101-105 • Jouney E.A. (2019). Phenibut (β-Phenyl-γ-Aminobutyric Acid): An easily obtainable "Dietary Supplement" with propensities for physical dependence and Addiction. Current Psychiatry Reports, 21(4), 23. doi: 10.1007/s11920-019-1009-0 • McCabe D.J, Bangh S.A, Arens A.M, & Cole J.B. (2019) Phenibut exposures and clinical effects reported to a regional poison center. American Journal of Emergency Medicine, 37(11), 2066-2071. doi: 10.1016/j.ajem.2019.02.044 • Savage S. and Ma D. (2014). The neurotoxicity of nitrous oxide: The facts and “putative” mechanisms. Brain Sciences, 4, 73-90. doi:10.3390/brainsci4010073 • Stinnett V.L. and. Kuhlmann K.L. (2018). Cannabinoid hyperemesis syndrome: An update for primary care providers. The Journal for Nurse Practitioners, 14(6),450-455
77